Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial.
Franek E, Pais P, Basile J, Nicolay C, Raha S, Hickey A, Ahmad NN, Konig M, Kan H, Gerstein HC. Franek E, et al. Among authors: ahmad nn. Cardiovasc Diabetol. 2023 Mar 10;22(1):52. doi: 10.1186/s12933-023-01757-z. Cardiovasc Diabetol. 2023. PMID: 36899386 Free PMC article. Clinical Trial.
Real-world primary nonadherence to antiobesity medications.
Kan H, Bae JP, Dunn JP, Buysman EK, Gronroos NN, Swindle JP, Bengtson LGS, Ahmad N. Kan H, et al. Among authors: ahmad n. J Manag Care Spec Pharm. 2023 Oct;29(10):1099-1108. doi: 10.18553/jmcp.2023.23083. Epub 2023 Aug 18. J Manag Care Spec Pharm. 2023. PMID: 37594848 Free PMC article.
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.
Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Griffin R, Stefanski A, Garvey WT. Hankosky ER, et al. Among authors: ahmad nn. Diabetes Obes Metab. 2024 Jan;26(1):319-328. doi: 10.1111/dom.15318. Epub 2023 Nov 6. Diabetes Obes Metab. 2024. PMID: 37932236 Clinical Trial.
Tirzepatide Once Weekly for the Treatment of Obesity.
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Jastreboff AM, et al. Among authors: ahmad nn. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658024 Clinical Trial.
45 results